Urelumab
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Urelumab |
| Trade Name | |
| Synonyms | BMS-663513|BMS663513|BMS 663513 |
| Drug Descriptions |
Urelumab (BMS-663513) is an activating monoclonal antibody that targets CD137, resulting in activation of CD137-expressing immune cells, thereby enhancing T-cell mediated response to tumor cells (PMID: 31143521, PMID: 32052473). |
| DrugClasses | TNFRSF9 Antibody 36 |
| CAS Registry Number | 934823-49-1 |
| NCIT ID | C62449 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + Urelumab | Cetuximab Urelumab | 0 | 1 |
| Cyclophosphamide + GVAX pancreatic cancer vaccine + Nivolumab + Urelumab | Cyclophosphamide GVAX pancreatic cancer vaccine Nivolumab Urelumab | 0 | 1 |
| Nivolumab + Urelumab | Nivolumab Urelumab | 0 | 5 |
| Relatlimab + Urelumab | Relatlimab Urelumab | 0 | 0 |
| Rituximab + Urelumab | Rituximab Urelumab | 0 | 0 |
| Urelumab | Urelumab | 0 | 4 |
CKB BOOST